Literature DB >> 2437517

The interaction of human T-lymphocytes and Entamoeba histolytica: killing of virulent amoebae by lectin-dependent lymphocytes.

R A Salata, J G Cox, J I Ravdin.   

Abstract

Clinical and experimental studies indicate that following invasive disease due to Entamoeba histolytica, development of human cell-mediated immune mechanisms may provide protective immunity. Activated, human monocyte-derived macrophages in vitro can kill virulent axaenic amoebic trophozoites. This study describes the interaction of lectin-stimulated T-lymphocytes and E. histolytica trophozoites (virulent strain HM1-IMSS). Amoebae progressively killed unstimulated nonimmune T-lymphocytes over 18 h incubation with no effect on amoebic viability. T-lymphocytes, stimulated with phytohaemagglutinin (PHA), were progressively cytotoxic for virulent HMI amoebae over 18 h incubation, but were also reduced in viability themselves. Lymphocyte cytotoxicity for amoebae was absent if PHA was removed before or added only during the assay. PHA-stimulated T-lymphocytes killed amoebae at cell ratios of lymphocytes to amoebae as low as 50:1 and cytotoxicity was antibody-independent. PHA-stimulated T-lymphocytes, depleted of T8-bearing cells by complement-mediated lysis, were unable to kill amoebae. Adherence of PHA-stimulated T-lymphocytes to amoebae was greater than with unstimulated T-lymphocytes. Inhibition of the amoebic adherence lectin with N-acetyl-D-galactosamine decreased lymphocyte-amoebic adherence and resulted in increased lymphocyte amoebicidal activity and lymphocyte survival. Suspension of amoebae with or without adherent PHA-stimulated T-lymphocytes in a 10% dextran solution indicated that cytotoxicity was contact dependent. In summary, PHA-stimulated T-lymphocytes of the T8-phenotype can kill virulent axaenic E. histolytica trophozoites through a contact-dependent, antibody-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437517     DOI: 10.1111/j.1365-3024.1987.tb00504.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.

Authors:  Xiaoti Guo; Lisa Barroso; David M Lyerly; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

Review 2.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

3.  Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica.

Authors:  D C Schain; R A Salata; J I Ravdin
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera.

Authors:  R A Salata; A Martinez-Palomo; L Canales; H W Murray; N Trevino; J I Ravdin
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

5.  Murine T-cell clones against Entamoeba histolytica: in vivo and in vitro characterization.

Authors:  M Denis; K Chadee
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

Review 6.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

7.  Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii.

Authors:  I A Khan; K A Smith; L H Kasper
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  Reduced expression of a rhomboid protease, EhROM1, correlates with changes in the submembrane distribution and size of the Gal/GalNAc lectin subunits in the human protozoan parasite, Entamoeba histolytica.

Authors:  Brenda H Welter; Heather A Walters; Lesly A Temesvari
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

9.  CD8(+) T cells in leishmania infections: friends or foes?

Authors:  Simona Stäger; Sima Rafati
Journal:  Front Immunol       Date:  2012-01-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.